NIAID Banner Logo Image

Other Viruses Citation List: March 1 - March 14, 2013

FIV

1. 9-[2-(R)-(Phosphonomethoxy)propyl]-2,6-diaminopurine (R)-PMPDAP and Its Prodrugs: Optimized Preparation, Including Identification of By-products Formed, and Antiviral Evaluation in Vitro. Krecmerova, M., P. Jansa, M. Dracinsky, P. Sazelova, V. Kasicka, J. Neyts, J. Auwerx, E. Kiss, N. Goris, G. Stepan, and Z. Janeba. Bioorganic & Medicinal Chemistry, 2013. 21(5): p. 1199-1208; PMID[23375089].

[PubMed] OV_0301-031413.

HCMV

2. Allium Sativum-derived Allitridin Inhibits TREG Amplification in Cytomegalovirus Infection. Li, Y.N., F. Huang, X.L. Liu, S.N. Shu, Y.J. Huang, H.J. Cheng, and F. Fang. Journal of Medical Virology, 2013. 85(3): p. 493-500; PMID[23341371].

[PubMed] OV_0301-031413.

Hepatitis B Virus

3. Synthesis of Hemslecin A Derivatives: A New Class of Hepatitis B Virus Inhibitors. Guo, R.H., C.A. Geng, X.Y. Huang, Y.B. Ma, Q. Zhang, L.J. Wang, X.M. Zhang, R.P. Zhang, and J.J. Chen. Bioorganic & Medicinal Chemistry Letters, 2013. 23(5): p. 1201-1205; PMID[23385212].

[PubMed] OV_0301-031413.


4. Synthesis and Biological Evaluation of Nucleoside Analogues Than Contain Silatrane on the Basis of the Structure of Acyclovir (ACV) as Novel Inhibitors of Hepatitis B Virus (HBV). Han, A., L. Li, K. Qing, X. Qi, L. Hou, X. Luo, S. Shi, and F. Ye. Bioorganic & Medicinal Chemistry Letters, 2013. 23(5): p. 1310-1314; PMID[23369536].

[PubMed] OV_0301-031413.

Hepatitis C Virus

5. Structure-based Discovery of Pyrazolobenzothiazine Derivatives as Inhibitors of Hepatitis C Virus Replication. Barreca, M.L., G. Manfroni, P. Leyssen, J. Winquist, N. Kaushik-Basu, J. Paeshuyse, R. Krishnan, N. Iraci, S. Sabatini, O. Tabarrini, A. Basu, U.H. Danielson, J. Neyts, and V. Cecchetti. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]; PMID[23409936].

[PubMed] OV_0301-031413.


6. Inhibition of Hepatitis C Viral RNA-dependent RNA Polymerase by alpha-P-Boranophosphate Nucleotides: Exploring a Potential Strategy for Mechanism-based HCV Drug Design. Cheek, M.A., M.L. Sharaf, M.I. Dobrikov, and B.R. Shaw. Antiviral Research, 2013. [Epub ahead of print]; PMID[23466667].

[PubMed] OV_0301-031413.


7. Lucidone Suppresses Hepatitis C Virus Replication by NRF2-mediated Heme Oxygenase-1 Induction. Chen, W.C., S.Y. Wang, C.C. Chiu, C.K. Tseng, C.K. Lin, H.C. Wang, and J.C. Lee. Antimicrobial Agents and Chemotherapy, 2013. 57(3): p. 1180-1191; PMID[23254429].

[PubMed] OV_0301-031413.


8. Sofosbuvir, a Nucleotide Polymerase Inhibitor, for the Treatment of Chronic Hepatitis C Virus Infection. Herbst, D.A., Jr. and K.R. Reddy. Expert Opinion on Investigational Drugs, 2013. [Epub ahead of print]; PMID[23448131].

[PubMed] OV_0301-031413.


9. Hepatoprotective and Antiviral Functions of Silymarin Components in Hepatitis C Virus Infection. Polyak, S.J., P. Ferenci, and J.M. Pawlotsky. Hepatology, 2013. 57(3): p. 1262-1271; PMID[23213025].

[PubMed] OV_0301-031413.


10. A Highly Convergent and Efficient Synthesis of a Macrocyclic Hepatitis C Virus Protease Inhibitor BI 201302. Wei, X., C. Shu, N. Haddad, X. Zeng, N.D. Patel, Z. Tan, J. Liu, H. Lee, S. Shen, S. Campbell, R.J. Varsolona, C.A. Busacca, A. Hossain, N.K. Yee, and C.H. Senanayake. Organic Letters, 2013. 15(5): p. 1016-1019; PMID[23406520].

[PubMed] OV_0301-031413.

HSV-1

11. HIV-1 and HSV-1 Virus Activities of Some New Polycyclic Nucleoside Pyrene Candidates. Khalifa, N.M., M.A. Al-Omar, G. Amr Ael, and M.E. Haiba. International Journal of Biological Macromolecules, 2013. 54: p. 51-56; PMID[23178400].

[PubMed] OV_0301-031413.

Citations from the ISI Web of Knowledge Listings for O.V.

12. New Therapeutic Strategies in HCV: Second-generation Protease Inhibitors. Clark, V.C., J.A. Peter, and D.R. Nelson. Liver International, 2013. 33: p. 80-84; ISI[000312999400012].

[WOS] OV_0301-031413.


13. Bicyclic Furano-, Pyrrolo-, and Thiopheno 2,3-D Derivatives of Pyrimidine Nucleosides: Synthesis and Antiviral Properties. Ivanov, M.A. and L.A. Aleksandrova. Russian Journal of Bioorganic Chemistry, 2013. 39(1): p. 22-39; ISI[000313960900002].

[WOS] OV_0301-031413.


14. Green Tea Phenolic Epicatechins Inhibit Hepatitis C Virus Replication Via Cycloxygenase-2 and Attenuate Virus-induced Inflammation. Lin, Y.T., Y.H. Wu, C.K. Tseng, C.K. Lin, W.C. Chen, Y.C. Hsu, and J.C. Lee. Plos One, 2013. 8(1): p. e54466; ISI[000314023600058].

[WOS] OV_0301-031413.


15. Identification of Type I and Type II Interferon-induced Effectors Controlling Hepatitis C Virus Replication. Metz, P., E. Dazert, A. Ruggieri, J. Mazur, L. Kaderali, A. Kaul, U. Zeuge, M.P. Windisch, M. Trippler, V. Lohmann, M. Binder, M. Frese, and R. Bartenschlager. Hepatology, 2012. 56(6): p. 2082-2093; ISI[000314288900041].

[WOS] OV_0301-031413.


16. Asymmetric Synthesis of Host-directed Inhibitors of Myxoviruses. Moore, T.W., K. Sana, D. Yan, P. Thepchatri, J.M. Ndungu, M.T. Saindane, M.A. Lockwood, M.G. Natchus, D.C. Liotta, R.K. Plemper, J.P. Snyder, and A.M. Sun. Beilstein Journal of Organic Chemistry, 2013. 9: p. 197-203; ISI[000314335100001].

[WOS] OV_0301-031413.


17. Stereoselective Addition of 2-Phenyloxazol-4-yl trifluoromethanesulfonate to N-Sulfinyl imines: Application to the Synthesis of the HCV Protease Inhibitor Boceprevir. Morris, W.J., K.K. Muppalla, C. Cowden, and R.G. Ball. Journal of Organic Chemistry, 2013. 78(2): p. 706-710; ISI[000314008700049].

[WOS] OV_0301-031413.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022